Telomerase — Drug Target

All drugs that target Telomerase — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Telomerase inhibitor · DNA vaccine, chemotherapy

Phase 3 pipeline (3)

• telomerase peptide vaccine GV1001 · Royal Liverpool University Hospital · Oncology
  GV1001 works by stimulating an immune response against telomerase, a protein often overexpressed in cancer cells.
• HU-014 · Huons Co., Ltd. · Telomerase inhibitor · Oncology
  HU-014 is a synthetic oligonucleotide that acts as a telomerase inhibitor.
• allovectin-7/dacarbazine · Vical · DNA vaccine, chemotherapy · Oncology
  Allovectin-7 is a DNA vaccine that targets telomerase, while dacarbazine is a chemotherapy drug that interferes with DNA replication.